Novel Aspiration Thrombectomy and Blood Reinfusion System for Acute Intermediate-Risk Pulmonary Embolism: AVENTUS Trial Results
This study confirms that thrombectomy and autologous blood reinfusion with the AVENTUS Thrombectomy System is a safe and effective primary treatment option in patients with acute intermediate-risk PE to improve RV function and reduce clot burden with minimal blood loss.
Authors
- David O’Connor (ORCID: https://orcid.org/0000-0002-4679-0840)
- Saher S. Sabri (ORCID: https://orcid.org/0009-0009-0386-0413)
- Michael Jolly (ORCID: https://orcid.org/0000-0002-6656-0030)
- Wissam Jaber (ORCID: https://orcid.org/0000-0003-1059-2436)
- N. Tabori
- Mehdi H. Shishehbor (ORCID: https://orcid.org/0000-0002-4888-2431)
- Raghu Kolluri (ORCID: https://orcid.org/0000-0002-4374-7513)
- Peter Monteleone (ORCID: https://orcid.org/0000-0003-4949-1421)
- Brian Stegman (ORCID: https://orcid.org/0009-0004-3992-2106)
- Christopher M. Huff
- Jun Li (ORCID: https://orcid.org/0000-0002-2064-4992)
- Ahmad Younes
- Samuel Horr
Institutions
- OhioHealth (US)
- Hackensack University Medical Center (US)
- Emory University (US)
- Georgetown University (US)
- University Hospitals of Cleveland (US)
- Riverside Methodist Hospital (US)
- ProMedica Toledo Hospital (US)
- MedStar Georgetown University Hospital (US)
- Centennial Medical Center (US)
- CentraCare Health System (US)
- The University of Texas at Austin (US)
Publication Details
- Journal
- Journal of the Society for Cardiovascular Angiography & Interventions
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1016/j.jscai.2025.103661
- Citations
- 1
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.87